Figure 8.
Correlation between overall survival of prostate cancer patients in YB-1, EGFR and CXCL14 expressing tissues. (a) The overall survival of prostate cancer patients with a high expression level of YB-1 was much lower than that of patients with a low level of YB-1(P = 0.0116); (b-d) There was no significant difference in the overall survival of prostate cancer patients with EGFR or CXCL14 expression levels or with Gleason score